expert meeting report · 9 aimed t osupp rt policymakers looking approaches. a literature review...

6 December 2019 London, United Kingdom

Forum to Explore the Role of Patient Organisations in VaccinationExpert Meeting Report

Authors Ms. Megan Acton Dr. Jane Barratt

Contents

Background 1

Barriers patient and health advocacy organisations face in advocating vaccination to their constituents 1

Good Practice 2

Health Policy Partnership 2

JDRF 2

Meningitis Now 3

Lupus UK 3

Age UK 4

Meningitis Research Foundation 4

British Lung Foundation 5

NAT (National AIDS Trust) and Positively UK 5

Conclusion and Next Steps 6

1. Continue the Momentum 6

2. Acknowledge and address barriers organisations may face in promoting vaccination 6

3. A Life Course Approach to Vaccination is Essential 7

4. Assuming Responsibility 7

5. Cross-Sectoral Collaboration 7

6. Forming Effective Messaging 7

References 8

1VACCINES4LIFE / FORUM TO EXPLORE THE ROLE OF PATIENT ORGANISATIONS IN VACCINATION

Pfizer had no involvement in the event or in the development of this report.

BackgroundPeople with chronic diseases such as HIV, heart disease and lung disease, as well as those with

1 The highest rates of pneumonia in the United Kingdom (UK), for example, are found amongst people with respiratory, heart and kidney disease,2

3 and adults living with HIV are at an approximately

adults.4

5

of individuals and their families.

brought unlike groups together and challenged them to look across sectors and disciplines and learn from one another.

Barriers patient and health advocacy organisations face in advocating vaccination to their constituents


The “Forum to Explore the Role of Patient Organisations in Vaccination” was fully funded by an unrestricted charitable donation from Pfizer UK.Pfizer had no involvement in the event or in the development of this report.

Good Practice

gaps, gaining an understanding of how common barriers have been addressed, and encouraging

a common agenda.

Health Policy Partnership

The Health Policy Partnership (HPP) is a specialist health policy consultancy that works to create

6

7 was undertaken to support engagement with policymakers to improve

video were then developed and launched at the European Health Forum.8

This body of work contributed to the dialogue on the inclusion of a life course approach in the

9 aimed to support policymakers looking

approaches. A literature review was conducted which informed interviews and case studies, drawing

comprehensively.10

an opportunity for all to hear ‘the other side of the story’ and work together to address barriers to

JDRF

works with academia, industry, and government to ensure that the lives of people with type 1 11



environmental triggers may play a role in the onset of type 1 diabetes, which in turn led to the

12

Meningitis Now

Their

the support they need to rebuild their lives.13

disease – A, B, C, W and Y. awareness of the importance of these vaccines, as well as vaccines that protect against other

.14

It is crucial that advocacy It is reasonable, for example, to deploy

of meningococcal disease amongst children and adolescents, which was published in the Lancet 15

Lupus UK

many others on the symptoms prior to diagnosis.16


17

their members in simple, clear messages. Lupus UK has, however, found it useful for their members

Age UK

Age UK is the country’s leading charity dedicated to helping everyone make the most out of later life,

policymakers.18

Every year, Age UK holds a ‘Keep Well This Winter’ health campaign, which encourages older people to take steps to ensure their health throughout the winter season.19 Within this campaign, a wide variety of health materials are disseminated including cold weather alerts and messaging through their website and social media.

As an element of the ‘Keep Well This Winter’ campaign, Age UK promotes the importance of

it is important to ‘go back to the basics’ in order to educate people and dispel myths surrounding

intermediaries and trusted groups.

Meningitis Research Foundation

20

21 MRF advocated

22

23




British Lung Foundation

campaigns to prevent lung disease.24

25 For these reasons, BLF is a strong advocate for

social media and website, including infographics that can be shared. BLF also conducts policy

NAT (National AIDS Trust) and Positively UK

NAT is the UK’s HIV policy and campaigning charity and is dedicated to transforming the UK’s

living with HIV in all aspects of life.

26

An

27

funding and provision across a wide range of services, including



There is confusing and but referral

services, including all recommended vaccines, to the GP clinic, with follow-up and with engagement

Conclusion and Next Steps

.spuorg ksir-ta fo htlaeh eht evorpmi dna niatniam ot redro ni desserdda eb ot sreirrab nommoc

change through the following areas:

1. Continue the Momentum

19.28

2. Acknowledge and address barriers organisations may face in promoting vaccination



3. A Life Course Approach to Vaccination is Essential

4. Assuming Responsibility

advice from a clinical expert.

5. Cross-Sectoral Collaboration

successfully.

6. Forming Effective Messaging

advice.

.segassem etairporppa dna lufgninaem dna ecneidua detegrat eht fo gnidnatsrednu gnorts a hguorht



References1

2 of vaccine preventable pneumococcal disease in UK adults. BMC pulmonary medicine , 16(1), 77

3

PloS one , 11(4), e0153848.

4 2015.

5 Vaccine, 21(7-8), 596-600.

6 Health Policy Partnership (2020). Home. [Webpage] Retrieved from

7

8

9

10

11 JDRF (2020) About Us. [Webpage] Retrieved from

12 Lalwani, A., Warren, J., Liuwantara, D., Hawthorne, W. J., O’Connell, P. J., Gonzalez, F. J., ... & Swarbrick, M. M. Cell reports, 27(8),

2370-2384.

13 are/

14

15 of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study. The Lancet Neurology , 11(9), 774-783.

16 Lupus UK (2020). About Us. [Webpage] Retrieved from

17

18 Age UK (2019). About Us. [Webpage] Retrieved from

19 Age UK (2019) Keep well this winter. [Webpage] Retrieved from wellbeing/keep-well-this-winter/

20

21



22

Statement_on_MenB.pdf

23

24

25

26 2015.

27 , 17: 619

28


The “Forum to Explore the Role of Patient Organisations in Vaccination” was funded by an unrestricted charitable donation from Pfizer UK. Pfizer had no involvement in the event or in the development of this consensus statement.

International Federation on Ageing 1 Bridgepoint Drive, Suite G.238 Toronto, ON, M4M 2B5, Canada

www.vaccines4life.com

Published May 2020 © Vaccines4Life

expert meeting report · 9 aimed t osupp rt policymakers looking approaches. a literature review...

Documents